Inactive Instrument

BioTelemetry, Inc.

Equities

BEAT

US0906721065

Healthcare Facilities & Services

BioTelemetry, Inc. to Release First Quarter 2015 Earnings Results on May 6, 2015

April 29, 2015 at 04:01 pm EDT

MALVERN, Pa., April 29, 2015 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (Nasdaq:BEAT) will release its first quarter 2015 earnings on Wednesday, May 6, 2015 at 4:00 PM Eastern Time.

The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 6, 2015. The broadcast will be available through the investor information section of the BioTelemetry website www.biotelinc.com. If you are unable to participate during the live webcast, an archive will be available on our website for two weeks.

About BioTelemetry

BioTelemetry, Inc., formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The Company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services. More information can be found at www.biotelinc.com.

CONTACT: BioTelemetry, Inc.
         Heather C. Getz
         Investor Relations
         800-908-7103
         InvestorRelations@biotelinc.com

Latest news about BioTelemetry, Inc.

Ayala Pharmaceuticals, Inc. announced that it has received $2 million in funding from Israel Biotech Fund, Arkin Bio Venture Partners Ltd., BioTelemetry, Inc.	Feb. 29	CI
Ayala Pharmaceuticals, Inc. entered into a definitive merger agreement to acquire BioSight Ltd from Israel Biotech Fund, BioTelemetry, Inc., Arkin Bio Venture Partners Ltd., Primera Capital, SBI JI Innovation Advisory Ltd., Migdal Insurance Company Ltd., The Phoenix Insurance Company Ltd. and others.	23-07-26	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Health Care Services Select Industry Index	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Composite 1500	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care Services (Sub Ind)	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 1000	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P TMI Index	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P Global BMI Index	21-02-10	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from S&P 600 Health Care	21-02-10	CI
BioTelemetry, Inc. Announces Board Changes	21-02-09	CI
BioTelemetry, Inc. Terminates Amended and Restated Credit Agreement	21-02-09	CI
Koninklijke Philips N : Royal Philips Completes Tender Offer to Acquire BioTelemetry at $72 per Share	21-02-09	MT
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from NASDAQ Composite Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2000 Growth-Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGS:BEAT) dropped from Russell 2500 Growth-Defensive Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Dynamic Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 3000 Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2500 Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell 2000 Growth Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell Small Cap Completeness Index	21-02-09	CI
BioTelemetry, Inc.(NasdaqGM:BEAT) dropped from Russell Small Cap Comp Growth Index	21-02-09	CI

Chart BioTelemetry, Inc.

Duration

Period

More charts

Company Profile

BioTelemetry, Inc. is a remote medical technology company focused on delivery of health information. The Company is principally engaged in providing remote cardiac monitoring, centralized core laboratory services for clinical trials, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers. The Company operates in two segments: Healthcare and Research. The Healthcare segment is focused on remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders and to monitor the functionality of implantable cardiac devices. It offers cardiologists, electrophysiologists and primary care physicians a full spectrum of solutions, which provides them with a single source of cardiac monitoring services. The Research segment is engaged in centralized core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials.

Sector

Healthcare Facilities & Services

More about the company

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-13.25%	87.77B
HCA HEALTHCARE, INC.	+18.01%	82.08B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+11.97%	30.03B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.50%	17.08B
FRESENIUS SE & CO. KGAA	-1.46%	16.41B
EUROFINS SCIENTIFIC SE	+4.44%	12.37B
FRESENIUS MEDICAL CARE AG	+5.11%	12.17B
PURE HEALTH HOLDING	-31.05%	11.89B
DAVITA INC.	+27.83%	11.62B

Other Healthcare Facilities & Services